474 related articles for article (PubMed ID: 16219424)
21. Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin.
Mahata M; Zhang K; Gayen JR; Nandi S; Brar BK; Ghosh S; Mahapatra NR; Taupenot L; O'Connor DT; Mahata SK
Cell Tissue Res; 2011 Jul; 345(1):87-102. PubMed ID: 21597914
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells.
Goto J; Otsuka F; Yamashita M; Suzuki J; Otani H; Takahashi H; Miyoshi T; Mimura Y; Ogura T; Makino H
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E904-16. PubMed ID: 19190257
[TBL] [Abstract][Full Text] [Related]
23. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction.
Jin L; Liu T; Lagoda GA; Champion HC; Bivalacqua TJ; Burnett AL
FASEB J; 2006 Mar; 20(3):536-8. PubMed ID: 16396994
[TBL] [Abstract][Full Text] [Related]
24. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat.
Sung JK; Miao L; Calvert JW; Huang L; Louis Harkey H; Zhang JH
Brain Res; 2003 Jan; 959(1):29-38. PubMed ID: 12480155
[TBL] [Abstract][Full Text] [Related]
25. Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKC.
Conrad S; Genth H; Hofmann F; Just I; Skutella T
J Biol Chem; 2007 Jun; 282(22):16423-33. PubMed ID: 17389603
[TBL] [Abstract][Full Text] [Related]
26. RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol.
Park SY; Lee SW; Lee WS; Rhim BY; Lee SJ; Kwon SM; Hong KW; Kim CD
Biochem Pharmacol; 2013 Nov; 86(9):1320-7. PubMed ID: 23973526
[TBL] [Abstract][Full Text] [Related]
27. PACAP stimulates the sustained phosphorylation of tyrosine hydroxylase at serine 40.
Bobrovskaya L; Gelain DP; Gilligan C; Dickson PW; Dunkley PR
Cell Signal; 2007 Jun; 19(6):1141-9. PubMed ID: 17261361
[TBL] [Abstract][Full Text] [Related]
28. Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.
Schlegel N; Meir M; Spindler V; Germer CT; Waschke J
J Cell Physiol; 2011 May; 226(5):1196-203. PubMed ID: 20945370
[TBL] [Abstract][Full Text] [Related]
29. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.
Pang H; Guo Z; Su W; Xie Z; Eto M; Gong MC
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C352-60. PubMed ID: 15814590
[TBL] [Abstract][Full Text] [Related]
30. Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells.
Radeff JM; Nagy Z; Stern PH
J Bone Miner Res; 2004 Nov; 19(11):1882-91. PubMed ID: 15476589
[TBL] [Abstract][Full Text] [Related]
31. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
32. Sevoflurane inhibits guanosine 5'-[gamma-thio]triphosphate-stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle.
Yu J; Ogawa K; Tokinaga Y; Hatano Y
Anesthesiology; 2003 Sep; 99(3):646-51. PubMed ID: 12960549
[TBL] [Abstract][Full Text] [Related]
33. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase.
Sauzeau V; Le Mellionnec E; Bertoglio J; Scalbert E; Pacaud P; Loirand G
Circ Res; 2001 Jun; 88(11):1102-4. PubMed ID: 11397774
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase.
Krijnen PA; Sipkens JA; Molling JW; Rauwerda JA; Stehouwer CD; Muller A; Paulus WJ; van Nieuw Amerongen GP; Hack CE; Verhoeven AJ; van Hinsbergh VW; Niessen HW
J Mol Cell Cardiol; 2010 Nov; 49(5):781-90. PubMed ID: 20691698
[TBL] [Abstract][Full Text] [Related]
35. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
36. The role of Rho kinase and extracellular regulated kinase-mitogen-activated protein kinase in alpha2-adrenoceptor-mediated vasoconstriction in the porcine palmar lateral vein.
Roberts RE
J Pharmacol Exp Ther; 2004 Nov; 311(2):742-7. PubMed ID: 15231868
[TBL] [Abstract][Full Text] [Related]
37. Urocortin stimulates tyrosine hydroxylase activity via the cAMP/protein kinase a pathway in rat Pheochromocytoma PC12 cells.
Nanmoku T; Takekoshi K; Fukuda T; Isobe K; Shibuya S; Kawakami Y
Neurosci Lett; 2005 Jul 1-8; 382(1-2):124-7. PubMed ID: 15911134
[TBL] [Abstract][Full Text] [Related]
38. Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.
Salvatore MF; Waymire JC; Haycock JW
J Neurochem; 2001 Oct; 79(2):349-60. PubMed ID: 11677263
[TBL] [Abstract][Full Text] [Related]
39. The mechanism by which RhoA regulates vascular reactivity after hemorrhagic shock in rats.
Li T; Fang Y; Yang G; Zhu Y; Xu J; Liu L
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H292-9. PubMed ID: 20472763
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling.
Essler M; Staddon JM; Weber PC; Aepfelbacher M
J Immunol; 2000 Jun; 164(12):6543-9. PubMed ID: 10843713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
